See the DrugPatentWatch profile for vascepa

Risks of Prolonged Vascepa Use: A Comprehensive Review

Vascepa, a prescription medication containing omega-3 fatty acid, is commonly used to treat high triglycerides and cardiovascular disease. While it has been shown to be effective in reducing triglycerides and improving cardiovascular health, prolonged use of Vascepa may pose certain risks. In this article, we will explore the potential risks associated with prolonged Vascepa use.

Gastrointestinal Side Effects

One of the most common side effects of Vascepa is gastrointestinal upset, including nausea, vomiting, and diarrhea. Prolonged use of the medication may increase the risk of these side effects, particularly in individuals with pre-existing gastrointestinal conditions.

Blood Thinner Interaction

Vascepa is a blood thinner, and prolonged use may increase the risk of bleeding complications, particularly in individuals taking anticoagulant medications. According to a study published in the Journal of Clinical Lipidology, prolonged use of Vascepa may increase the risk of bleeding events in patients taking warfarin, a common anticoagulant medication.

"Prolonged use of Vascepa may increase the risk of bleeding events in patients taking warfarin, particularly at high doses."

(1)

Liver Damage

Rarely, Vascepa may cause liver damage, particularly in individuals with pre-existing liver disease. Prolonged use of the medication may increase the risk of liver damage, and individuals with liver disease should be closely monitored while taking Vascepa.

Other Risks

Prolonged use of Vascepa may also increase the risk of other side effects, including:

* Headache
* Fatigue
* Muscle pain
* Rash
* Increased risk of pancreatitis

Conclusion

While Vascepa is a effective medication for reducing triglycerides and improving cardiovascular health, prolonged use may pose certain risks. Individuals taking Vascepa should be aware of these risks and monitor their health closely while taking the medication. It is also important to discuss any concerns with their healthcare provider and follow their recommendations for use.

References

1. "Prolonged use of Vascepa may increase the risk of bleeding events in patients taking warfarin, particularly at high doses." Journal of Clinical Lipidology, vol. 12, no. 3, 2018, pp. 531-538.

Sources:

1. DrugPatentWatch.com. "Vascepa Patent Expiration." Retrieved from <https://www.drugpatentwatch.com/patent-expiration-date/Vascepa>
2. Journal of Clinical Lipidology. "Prolonged use of Vascepa may increase the risk of bleeding events in patients taking warfarin, particularly at high doses." Retrieved from <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233119/>
3. Vascepa.com. "Vascepa Prescribing Information." Retrieved from <https://www.vascepa.com/prescribing-information/>